Skip to main content
Evidence Snapshot

Penicillin-binding protein 2

CHEMBL3825 SINGLE PROTEIN Staphylococcus aureus
Source Header

ChEMBL 36 via Core Engine

Target Snapshot 2026-09-13T15:52:22Z
Source · ChEMBL 36 via Core Engine
ChEMBL ChEMBL 36 CHEMBL3825
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Penicillin-binding protein 2 as ChEMBL target CHEMBL3825, mapped to UniProt Q53729. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Penicillin-binding protein 2
SINGLE PROTEIN · Staphylococcus aureus
As of 2026-09-13
ChEMBL target ID
CHEMBL3825
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q53729
Penicillin-binding protein 2
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Review-ready Target Rationale

Why Penicillin-binding protein 2 matters

As of 2026-09-13

Penicillin-binding protein 2 is reviewed as Penicillin-binding protein 2 (UniProt Q53729); Penicillin-binding protein 2 shows approved-linked disease relevance led by bacteriemia. 5 more disease programs remain visible in the same review block.; 1 linked drug keep this evidence frame grounded.; the current evidence base includes 0 approved drugs, 28 compounds, and 12 assays, with lead potency reaching pChEMBL 5.4.

Disease context
bacteriemia

Penicillin-binding protein 2 shows approved-linked disease relevance led by bacteriemia. 5 more disease programs remain visible in the same review block. 1 linked drug keep the rationale reviewable. 5 additional disease programs remain visible in the same card. Linked drugs include CEFTOBIPROLE MEDOCARIL SODIUM.

Start review with bacteriemia because it currently carries approved-linked support. Linked drugs include CEFTOBIPROLE MEDOCARIL SODIUM. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.

ChEMBL target record
Approved-linked 1 linked drug
Activity base
Portfolio and assay base

ChEMBL currently tracks 0 approved drugs, 28 compounds, and 12 assays for this target. The dominant activity type is IC50. CHEMBL123481 is the current potency anchor at pChEMBL 5.4.

Use CHEMBL123481 as the tractability anchor when discussing potency (pChEMBL 5.4).

Activity source · ChEMBL 36 via Core Engine
pChEMBL 5.4
Source Guidance

Start with the right source

Pick the first block or linked source that matches the review question in front of you.

Need the shortest review narrative first?
Review-ready Target Rationale
One-page rationale with as-of-date and attribution

Start with the review rationale when you need to explain why Penicillin-binding protein 2 matters before drilling into raw source blocks.

Jump to Review Rationale
Need stable protein naming or accession mapping?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Go back to the target snapshot when you need the naming and mapping contract behind UniProt Q53729, not just the summarized rationale.

Open Protein Context
Need disease fit or evidence level for program framing?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use the target snapshot disease block when you need to see why bacteriemia is currently treated as approved-linked support.

Open Disease Context

Snapshot State

No project snapshot selected. Export uses the live evidence card state.

28
Total Compounds
12
Total Assays
0
Approved Drugs
IC50: 35.0
Activity Types

pChEMBL Activity Distribution

Top 5 Inhibitors (by pChEMBL)

Structure Compound pChEMBL Type Phase
No preferred name
CHEMBL123481
 5.4 IC50 —
No preferred name
CHEMBL6461
 5.3 IC50 —
No preferred name
CHEMBL332565
 4.8 IC50 —
No preferred name
CHEMBL3746902
 4.7 IC50 —
No preferred name
CHEMBL333330
 4.5 IC50 —
← Target Page
Source Header

ChEMBL 36 via Core Engine

Target Snapshot 2026-09-13T15:52:22Z
Source · ChEMBL 36 via Core Engine
ChEMBL ChEMBL 36 CHEMBL3825